The transcriptional regulator ADNP links the BAF (SWI/SNF) complexes with autism
暂无分享,去创建一个
B. Coe | A. V. Vulto-van Silfhout | B. D. de Vries | C. Romano | E. Eichler | R. Bernier | A. Nordgren | T. Kleefstra | Meredith Wilson | R. Kooy | A. van Dijck | J. van den Ende | J. Gerdts | G. Vandeweyer | C. Helsmoortel | N. van der Aa | Omar A. Abdulrahman | Madhura Bakshi | L. Hendon | L. Rooms | R. Frank Kooy | Anneke T. Vulto‐van Silfhout | Bradley P. Coe | Laura G. Hendon | Omar A. Abdulrahman
[1] R. Kooy,et al. Challenges and opportunities in the investigation of unexplained intellectual disability using family‐based whole‐exome sequencing , 2015, Clinical genetics.
[2] I. Gozes,et al. Davunetide: Peptide therapeutic in neurological disorders. , 2014, Current medicinal chemistry.
[3] C. Hultman,et al. The familial risk of autism. , 2014, JAMA.
[4] Z. Warren,et al. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014 , 2018, Morbidity and mortality weekly report. Surveillance summaries.
[5] Stephen J. Guter,et al. Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders , 2014, American journal of human genetics.
[6] Kali T. Witherspoon,et al. A SWI/SNF related autism syndrome caused by de novo mutations in ADNP , 2014, Nature Genetics.
[7] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[8] J. Shendure,et al. A de novo convergence of autism genetics and molecular neuroscience , 2014, Trends in Neurosciences.
[9] A. V. Vulto-van Silfhout,et al. Coffin–Siris Syndrome and the BAF Complex: Genotype–Phenotype Study in 63 Patients , 2013, Human mutation.
[10] Magalie S Leduc,et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.
[11] Y. Fukushima,et al. Clinical correlations of mutations affecting six components of the SWI/SNF complex: Detailed description of 21 patients and a review of the literature , 2013, American journal of medical genetics. Part A.
[12] S. Scherer,et al. Autism spectrum disorder in the genetics clinic: a review , 2013, Clinical genetics.
[13] Wei Wu,et al. From neural development to cognition: unexpected roles for chromatin , 2013, Nature Reviews Genetics.
[14] Eric M. Morrow,et al. Using Whole-Exome Sequencing to Identify Inherited Causes of Autism , 2013, Neuron.
[15] I. Gozes,et al. NAP Alpha-Aminoisobutyric Acid (IsoNAP) , 2013, Journal of Molecular Neuroscience.
[16] Bradley P. Coe,et al. Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders , 2012, Science.
[17] I. Gozes,et al. The ADNP Derived Peptide, NAP Modulates the Tubulin Pool: Implication for Neurotrophic and Neuroprotective Activities , 2012, PloS one.
[18] B. V. van Bon,et al. Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.
[19] D. Horn,et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.
[20] Allan Jacobson,et al. NMD: a multifaceted response to premature translational termination , 2012, Nature Reviews Molecular Cell Biology.
[21] J. Veltman,et al. De novo mutations in human genetic disease , 2012, Nature Reviews Genetics.
[22] Tadashi Kaname,et al. New from NPG , 2012, Nature Medicine.
[23] Bradley P. Coe,et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.
[24] R. Kooy,et al. Advances in understanding fragile X syndrome and related disorders , 2011, Current opinion in pediatrics.
[25] Kathryn Roeder,et al. Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism , 2011, Neuron.
[26] I. Gozes,et al. Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: Deregulation in schizophrenia , 2011, European Neuropsychopharmacology.
[27] I. Gozes. Microtubules, schizophrenia and cognitive behavior: Preclinical development of davunetide (NAP) as a peptide-drug candidate , 2011, Peptides.
[28] W. Fischle,et al. HP1 Recruits Activity-Dependent Neuroprotective Protein to H3K9me3 Marked Pericentromeric Heterochromatin for Silencing of Major Satellite Repeats , 2011, PloS one.
[29] Christian Gilissen,et al. A de novo paradigm for mental retardation , 2010, Nature Genetics.
[30] Gary D Bader,et al. Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.
[31] G. Crabtree,et al. Chromatin remodelling during development , 2010, Nature.
[32] G. B. Schaefer,et al. Genetic evaluation of autism. , 2008, Seminars in pediatric neurology.
[33] J. Quinn,et al. Expression of activity-dependent neuroprotective protein in the brain of adult rats. , 2008, Histology and histopathology.
[34] I. Gozes,et al. ADNP Differential Nucleus/Cytoplasm Localization in Neurons Suggests Multiple Roles in Neuronal Differentiation and Maintenance , 2008, Journal of Molecular Neuroscience.
[35] I. Gozes,et al. Activity-dependent Neuroprotective Protein Constitutes a Novel Element in the SWI/SNF Chromatin Remodeling Complex* , 2007, Journal of Biological Chemistry.
[36] O. Touloumi,et al. Activity-Dependent Neuroprotective Protein Snippet NAP Reduces Tau Hyperphosphorylation and Enhances Learning in a Novel Transgenic Mouse Model , 2007, Journal of Pharmacology and Experimental Therapeutics.
[37] R. Aebersold,et al. An Essential Switch in Subunit Composition of a Chromatin Remodeling Complex during Neural Development , 2007, Neuron.
[38] G. Rechavi,et al. Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis. , 2007, Developmental biology.
[39] Christian von Mering,et al. STRING 7—recent developments in the integration and prediction of protein interactions , 2006, Nucleic Acids Res..
[40] I. Gozes,et al. NAP mechanisms of neuroprotection , 2007, Journal of Molecular Neuroscience.
[41] Bruce H. Morimoto,et al. NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP). , 2006, CNS drug reviews.
[42] I. Gozes,et al. Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes. , 2004, Neuron glia biology.
[43] A. Goldsweig,et al. Activity-dependent neuroprotective protein: a novel gene essential for brain formation. , 2003, Brain research. Developmental brain research.
[44] Douglas Wahlsten,et al. In search of a better mouse test , 2003, Trends in Neurosciences.
[45] I. Gozes,et al. NAP, a Femtomolar-Acting Peptide, Protects the Brain Against Ischemic Injury by Reducing Apoptotic Death , 2002, Stroke.
[46] E. Seroussi,et al. Cloning and Characterization of the Human Activity-dependent Neuroprotective Protein* , 2001, The Journal of Biological Chemistry.
[47] I. Gozes,et al. A Novel VIP Responsive Gene: Activity Dependent Neuroprotective Protein , 2000, Annals of the New York Academy of Sciences.
[48] I. Gozes,et al. Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze. , 2000, The Journal of pharmacology and experimental therapeutics.
[49] H. Zoghbi,et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.
[50] J. Crabbe,et al. Genetics of mouse behavior: interactions with laboratory environment. , 1999, Science.
[51] H. Bassan,et al. Complete Sequence of a Novel Protein Containing a Femtomolar‐Activity‐Dependent Neuroprotective Peptide , 1999, Journal of neurochemistry.
[52] S. Said. Molecules that protect: the defense of neurons and other cells. , 1996, The Journal of clinical investigation.
[53] C. Gillberg,et al. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. , 1989, Journal of child psychology and psychiatry, and allied disciplines.
[54] J. Garland. The New England Journal of Medicine. , 1961, Canadian Medical Association journal.
[55] S. Folstein,et al. Genetic influences and infantile autism , 1977, Nature.